Related Experiment Video
Updated: May 12, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Time to goal hemoglobin A1c with pharmacist management compared with nonpharmacist management
Background:
Although there is robust literature showing pharmacist success reducing hemoglobin A1c% (A1c), studies evaluating the impact of pharmacists on time to goal A1c are lacking. This study aimed to assess the difference in time to achieve diabetes control with pharmacist management compared with nonpharmacist management.
Objectives:
The primary objective was average time to achieve goal A1c with pharmacist management compared with nonpharmacist management. Secondary objectives included the rate of achieving goal A1c, mean A1c reduction, rate of hospitalization and emergency department visits, and the use of guideline-directed therapy in eligible patients (appropriateness of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and statin or proprotein convertase subtilisin/kexin type 9 inhibitor use).
Methods:
This was a retrospective, single-center chart review of adult patients followed by primary care providers at a large academic health system. Patients with a referral to a pharmacist for diabetes management (pharmacist group) were compared with patients managed without pharmacist involvement (nonpharmacist group). Those in the nonpharmacist group received support from the chronic care management team, which included a primary care provider, a diabetes educator, a dietitian, and a nurse who assists with medication adherence.
Results:
Of the 355 patients evaluated, 238 were included with 189 patients in the pharmacist group and 49 patients in the nonpharmacist group. Time to achieve goal A1c occurred sooner in patients managed by the pharmacist than the nonpharmacist group (8.8 ± 5.3 months vs. 22.5 ± 13.0 months, respectively, P = 0.001).
Conclusion:
Pharmacist management of diabetes resulted in patients achieving their goal A1c approximately 14 months faster than those who did not receive pharmacist support. However, the results of the study do not take into consideration different comorbidities, length of disease, and specific medication classes used, which may have potentially affected the results.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Hypoglycemia and Glucagon
Errors occurring during blood pressure monitoring
Several factors...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Diabetes Mellitus: Type 2 and Gestational

